Cargando…

Therapeutics of Alzheimer’s Disease: Recent Developments

With increasing aging, dementia is a growing public health concern globally. Patients with dementia have multiple psychological and behavioral changes, including depression, anxiety, inappropriate behavior, paranoia, agitation, and hallucinations. The major types of dementia are Alzheimer’s disease...

Descripción completa

Detalles Bibliográficos
Autores principales:	Burns, Scott, Selman, Ashley, Sehar, Ujala, Rawat, Priyanka, Reddy, Arubala P., Reddy, P. Hemachandra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9774459/ https://www.ncbi.nlm.nih.gov/pubmed/36552610 http://dx.doi.org/10.3390/antiox11122402

Ejemplares similares

Amyloid Beta in Aging and Alzheimer’s Disease
por: Sehar, Ujala, et al.
Publicado: (2022)

Phosphorylated Tau in Alzheimer’s Disease and Other Tauopathies
por: Rawat, Priyanka, et al.
Publicado: (2022)

Support Provided by Caregivers for Community-Dwelling Obesity Individuals: Focus on Elderly and Hispanics
por: Basu, Tanisha, et al.
Publicado: (2023)

Support Provided by Caregivers for Community-Dwelling Diabetic Hispanic Adults with Intellectual Disabilities and Comorbid Conditions
por: Rawat, Priyanka, et al.
Publicado: (2023)

Caregivers with Cancer Patients: Focus on Hispanics
por: Bisht, Jasbir, et al.
Publicado: (2023)

Alzheimer’s Disease and Alzheimer’s Disease-Related Dementias in African Americans: Focus on Caregivers
por: Kopel, Jonathan, et al.
Publicado: (2023)

The Role of Obesity and Diabetes in Dementia
por: Selman, Ashley, et al.
Publicado: (2022)

Current Status of Obesity: Protective Role of Catechins
por: Basu, Tanisha, et al.
Publicado: (2023)

Comprehensive Understanding of Hispanic Caregivers: Focus on Innovative Methods and Validations
por: Sehar, Ujala, et al.
Publicado: (2023)

Lifestyle Modifications and Nutritional Interventions in Aging-Associated Cognitive Decline and Alzheimer’s Disease
por: Bhatti, Gurjit Kaur, et al.
Publicado: (2020)

Mitochondrial Oxidative Damage in Aging and Alzheimer's Disease: Implications for Mitochondrially Targeted Antioxidant Therapeutics
por: Reddy, P. Hemachandra
Publicado: (2006)

Therapeutic Strategies in the Development of Anti-viral Drugs and Vaccines Against SARS-CoV-2 Infection
por: Bhatti, Jasvinder Singh, et al.
Publicado: (2020)

COVID-19 and Rheumatoid Arthritis Crosstalk: Emerging Association, Therapeutic Options and Challenges
por: Dewanjee, Saikat, et al.
Publicado: (2021)

Dynamics of Dynamin-Related Protein 1 in Alzheimer’s Disease and Other Neurodegenerative Diseases
por: Oliver, Darryll, et al.
Publicado: (2019)

Age-Related Chronic Diseases and Alzheimer’s Disease in Texas: A Hispanic Focused Study
por: Sheladia, Shyam, et al.
Publicado: (2021)

Are mitophagy enhancers therapeutic targets for Alzheimer’s disease?
por: Pradeepkiran, Jangampalli Adi, et al.
Publicado: (2022)

Targeting mitochondrial bioenergetics as a promising therapeutic strategy in metabolic and neurodegenerative diseases
por: Bhatti, Gurjit Kaur, et al.
Publicado: (2022)

Early Cellular, Molecular, Morphological and Behavioral Changes in the Humanized Amyloid-Beta-Knock-In Mouse Model of Late-Onset Alzheimer’s Disease
por: Kshirsagar, Sudhir, et al.
Publicado: (2022)

Emerging role of non‐coding RNA in health and disease
por: Bhatti, Gurjit Kaur, et al.
Publicado: (2021)

Amyloid Beta and Phosphorylated Tau-Induced Defective Autophagy and Mitophagy in Alzheimer’s Disease
por: Reddy, P. Hemachandra, et al.
Publicado: (2019)

A Combination Therapy of Urolithin A+EGCG Has Stronger Protective Effects than Single Drug Urolithin A in a Humanized Amyloid Beta Knockin Mice for Late-Onset Alzheimer’s Disease
por: Kshirsagar, Sudhir, et al.
Publicado: (2022)

Defective Autophagy and Mitophagy in Aging and Alzheimer’s Disease
por: Tran, Michael, et al.
Publicado: (2021)

Mitochondrial Dysfunction and Oxidative Stress in Asthma: Implications for Mitochondria-Targeted Antioxidant Therapeutics
por: Reddy, P. Hemachandra
Publicado: (2011)

Mitochondria-Targeted Antioxidant SS31 Prevents Amyloid Beta-Induced Mitochondrial Abnormalities and Synaptic Degeneration in Alzheimer’s Disease
por: Calkins, Marcus J., et al.
Publicado: (2012)

Can healthy lifestyle reduce disease progression of Alzheimer’s during a global pandemic of COVID-19?
por: John, Albin, et al.
Publicado: (2021)

MicroRNA-455-3p as a Potential Biomarker for Alzheimer's Disease: An Update
por: Kumar, Subodh, et al.
Publicado: (2018)

Protective Effects of Chaya against Mitochondrial and Synaptic Toxicities in the Type 2 Diabetes Mouse Model TallyHO
por: Ramasubramanian, Bhagavathi, et al.
Publicado: (2022)

Neurotransmitter CART as a New Therapeutic Candidate for Parkinson’s Disease
por: Mao, Peizhong, et al.
Publicado: (2013)

Toxicity of Neurons Treated with Herbicides and Neuroprotection by Mitochondria-Targeted Antioxidant SS31
por: Reddy, Tejaswini P., et al.
Publicado: (2011)

Structure Based Design and Molecular Docking Studies for Phosphorylated Tau Inhibitors in Alzheimer’s Disease
por: Pradeepkiran, Jangampalli Adi, et al.
Publicado: (2019)

Amyloid Beta and MicroRNAs in Alzheimer’s Disease
por: Amakiri, Nnana, et al.
Publicado: (2019)

Therapeutic Effects of BT2 in the Hippocampus of Alzheimer's Disease Mouse Model
por: Mullins, Caitlyn, et al.
Publicado: (2022)

Reduced VDAC1, Maintained Mitochondrial Dynamics and Enhanced Mitochondrial Biogenesis in a Transgenic Tau Mouse Model of Alzheimer’s Disease
por: Vijayan, Murali, et al.
Publicado: (2022)

Rlip Reduction Induces Oxidative Stress and Mitochondrial Dysfunction in Mutant Tau-Expressed Immortalized Hippocampal Neurons: Mechanistic Insights
por: Reddy, P. Hemachandra, et al.
Publicado: (2023)

Recent advances in molecular pathways and therapeutic implications targeting neuroinflammation for Alzheimer’s disease
por: Dhapola, Rishika, et al.
Publicado: (2021)

Rlip76: An Unexplored Player in Neurodegeneration and Alzheimer’s Disease?
por: Hindle, Ashly, et al.
Publicado: (2022)

Ovarian steroids regulate gene expression related to DNA repair and neurodegenerative diseases in serotonin neurons of macaques
por: Bethea, Cynthia L., et al.
Publicado: (2015)

Mitochondrial MicroRNAs in Aging and Neurodegenerative Diseases
por: John, Albin, et al.
Publicado: (2020)

Recent developments in Alzheimer's disease therapeutics
por: Rafii, Michael S, et al.
Publicado: (2009)

Current Status of Multiple Drug Molecules, and Vaccines: An Update in SARS-CoV-2 Therapeutics
por: Kandimalla, Ramesh, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_l91pdj7oim6kt05gdi9scoovf0